MYCL-mediated reprogramming expands pancreatic insulin-producing cells

Area of Science:

• Endocrinology
• Cell Biology
• Regenerative Medicine

Background:

• Beta cells have limited regenerative capacity, increasing diabetes risk.
• MYC family proteins regulate cell proliferation.

Purpose of the Study:

• Investigate the role of MYC family members in pancreatic endocrine cell proliferation.
• Determine if Mycl can be used to regenerate beta cells for diabetes treatment.

Main Methods:

• Genetic ablation of Mycl in neonatal mice.
• Mycl expression in adult mice (in vivo).
• Mycl expression in isolated human islet cells (in vitro).

Main Results:

• Mycl ablation reduced neonatal pancreatic endocrine cell proliferation.
• Mycl expression in adult mice stimulated beta and alpha cell proliferation.
• Expanded alpha cells transdifferentiated into insulin-producing cells.
• Transient Mycl expression normalized hyperglycemia in diabetic mice.
• Mycl induced replication in aged mouse and human islet cells.

Conclusions:

• Mycl is a key regulator of pancreatic endocrine cell proliferation.
• Mycl induction expands functional beta cell populations.
• Mycl represents a potential regenerative strategy for beta cells in diabetes.